| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |